cd-20 antibodies in chronic lymphocytic leukemia
Published 8 years ago • 834 plays • Length 8:24Download video MP4
Download video MP3
Similar videos
-
7:04
anti-cd20 antibodies used in treating chronic lymphocytic leukemia
-
21:17
new anti-cd20 antibodies for cll - are they better than rituximab?
-
5:07
cd20-targeted antibodies with novel agents for cll
-
4:55
case 1: ibrutinib /- cd20 antibodies in cll
-
1:33
dr. awan on remaining questions with btk inhibitors and anti-cd20 combos in cll
-
2:08
the use of cd20 antibodies in cll patients with notch1 mutations
-
6:00
anti-cd20 antibodies
-
1:21
emerging anti-cd20 monoclonal antibodies as first-line therapy in elderly cll
-
7:02
frontline treatment options in cll
-
7:29
btk inhibitor with vs without a cd20-targeted antibody
-
3:23
cd19 and cd20 antibodies in development
-
2:25
anti-cd20 antibody therapy in first-line mzl
-
5:50
idelalisib in chronic lymphocytic leukemia
-
1:03
dr. eradat on rituximab biosimilar in cd20 b-cell nhl and cll
-
5:58
the role of ofatumumab in chronic lymphocytic leukemia treatment
-
1:27
dr. sehn discusses the efficacy of the cd20 agent ga101
-
12:53
selecting first-line treatment for chronic lymphocytic leukemia (cll)
-
4:07
rituximab, obinutuzumab, and ofatumumab in cll
-
9:48
optimal combination and sequence of chronic lymphocytic leukemia therapies